جستجوی استاد راهنمای دانشگاهی

Aivi T. Nguyenمشاهده پروفایل

استادیار بالینی

• Neurodegeneration
• Alzheimer's Disease
• Microglia
• +۳ مورد دیگر

Aivi T. Nguyen, M.D., serves as a Clinical Assistant Professor in the Department of Laboratory Medicine and Pathology at Mayo Clinic Alix School of Medicine. As a board-certified neuropathologist and translational researcher, she spearheads investigations into neuroinflammation mechanisms in neurodegenerative diseases through the Alzheimer's Disease Research Center (ADRC) and Mayo Clinic Study of Aging (MCSA), integrating neuropathology with neuroimaging and biomarker analysis. Her educational trajectory includes: Post Doctoral Fellowship, Translational Neuropathology Research Laboratory (University of Pennsylvania, 2020) Neuropathology Fellowship (Hospital of the University of Pennsylvania, 2018) Anatomic Pathology Residency (Hospital of the University of Pennsylvania, 2016) M.D. (Jefferson Medical College, 2014) Research Fellowship (NIH Medical Research Scholars Program, 2013) B.S. in Cell and Molecular Biology, Genetics (University of Delaware, 2009) Dr. Nguyen's research centers on microglial heterogeneity in Alzheimer's disease, employing single-nuclei RNA sequencing and immunohistochemical validation to characterize distinct microglial subpopulations. She investigates how genetic risk variants (APOE E4, TREM2 R47H) modulate microglial responses to proteinopathies and explores microglia's role in cognitive resilience despite pathological burden. Her work bridges molecular mechanisms with clinical manifestations through multidisciplinary approaches. Analysis of her 2020-2025 publications reveals consistent focus on microglial biology across neurodegenerative conditions, with increasing emphasis on genetic determinants and translational applications. Recent work expands into TDP-43 proteinopathies and cerebral amyloid angiopathy while maintaining core investigation of microglial dynamics in Alzheimer's disease. Her accolades include: Two Diagnostic Slide Session Awards for Best Neurodegenerative Case (American Association of Neuropathology, 2021 & 2018) Neurodegenerative Disease Scholars Program Award and Robert Terry Award Honorable Mention (2020) Penn Cares Grant for 'Woodland Writers' Project (2015) Harold L. Stewart Prize in Pathology (2014) Dr. Nguyen actively shapes neuropathology standards through committee roles including the American Board of Pathology Test Development Advisory Committee and American Association of Neuropathologists Education Committee. Her research is supported by institutional resources within Mayo Clinic's ADRC infrastructure and collaborative multi-institutional grants. She operates within Mayo Clinic's integrated research ecosystem, contributing neuropathological expertise to the ADRC and MCSA teams while participating in national consortia studying neurodegenerative mechanisms. Her laboratory work focuses on human tissue analysis with emphasis on microglial transcriptomics and spatial pathology mapping.

• Neuroimaging
• Brain Mapping
• Computational Neuroscience
• +۴ مورد دیگر

Paul M. Thompson, PhD is a Professor at the Keck School of Medicine of the University of Southern California, with appointments across 8 departments including Neurology, Psychiatry, Biomedical Engineering, and Quantitative & Computational Biology. He leads the ENIGMA Consortium , a global network of 2500+ scientists across 47 countries conducting large-scale neuroimaging-genetics studies of 30+ brain disorders. His research integrates neuroimaging, mathematics, computer science , and clinical medicine to map brain diseases and develop AI tools for early detection. Education: MA in Mathematics & Classics (Oxford), PhD in Neuroscience (UCLA) Labs: Director of the USC Imaging Genetics Center (50+ researchers) and $11M NIH ENIGMA Center for Worldwide Medicine, Imaging & Genomics Key research areas include: Alzheimer’s Disease : Identifying genetic risk variants and AI-driven subtyping for novel treatment targets Psychiatric Disorders : Mapping brain changes in schizophrenia, depression, OCD, and bipolar illness Developmental Neuroscience : Tracking brain growth in children and fetal programming effects Global Health : India ENIGMA Initiative studying brain aging in diverse populations His recent publications focus on deep learning for MRI analysis , diffusion models for synthetic imaging , and genetic correlates of brain structure in journals like Nature Genetics , Science , and Nature . Major Awards : 2023 Society for Brain Mapping & Therapeutics: Pioneer in Medicine Award 2021 U.S. Alzheimer Association: Zenith Award 2015 Kent Innovations in Academia Award Leadership : Director, ENIGMA Center for Worldwide Medicine ($11M NIH) Director, AI4AD ($18M NIH Initiative) Founder, India ENIGMA Initiative

Thomas Buddeمشاهده پروفایل

استاد

• Molecular and Cellular Physiology
• Neurophysiology
• Electrophysiology
• +۷ مورد دیگر

Prof. Thomas Budde is a Professor at the Institute of Physiology I (Neurophysiology), University of Muenster, Germany. He is actively involved in the 'Cells in Motion' research initiative. His work focuses on the molecular and cellular physiology of the thalamocortical system, with expertise in cellular imaging and electrophysiology. Key research themes include analysis of neuronal network function, oscillations, neuroinflammation, and ion channel biology. Research Interests: Thalamocortical system dynamics, ion channel modulation, neuroinflammation, and electrophysiological network analysis. Techniques: Electrophysiology, PET imaging, fluorescent probes, computational modeling of neuronal activity. His publications highlight contributions to understanding K⁺ channel roles in tumor cells, autoimmune encephalomyelitis, and thalamic oscillatory activity. Recent work explores anesthesia's impact on BOLD signals and HCN4 channel regulation in brain networks. Collaborations include imaging network projects and drug development for neuroinflammatory conditions. Labs/Teams: Participates in the Multiscale Imaging Centre and collaborative research networks targeting neuroinflammation and ion channel dysfunction.

Gabriele Endeمشاهده پروفایل

استاد مدعو

• Neuroimaging
• Psychiatry
• Magnetic Resonance Spectroscopy
• +۳ مورد دیگر

Prof. (apl.) Gabriele Ende is an Adjunct Professor at the Department of Neuroimaging within the Medical Faculty Mannheim at Heidelberg University. Her primary affiliation is with the Central Institute of Mental Health (Zentralinstitut für Seelische Gesundheit) in Mannheim. She specializes in translational neuroimaging research, focusing on developing multimodal imaging biomarkers for psychiatric diseases. Her work integrates neurochemistry, functional MRI, and spectroscopy to understand the relationship between neural activity, neurotransmitter concentrations (e.g., GABA and glutamate), and clinical symptoms in conditions like Borderline Personality Disorder (BPD) and alcohol addiction. Research interests include: Development of neuroimaging methods (e.g., hyperscanning, awake-state fMRI in animals) Neurochemical correlates of impulsivity and pain processing in BPD Translational studies using rodent models to bridge human and animal research Neurofeedback interventions targeting amygdala activity and prefrontal-limbic connectivity Her lab utilizes cutting-edge facilities, including 3T MRI scanners (with multinuclear capabilities) and a 9.4T animal scanner. Recent projects emphasize the role of GABA and glutamate in brain connectivity, particularly in the fronto-striatal network and ACC-caudate pathways. Key collaborations involve interdisciplinary teams at the Central Institute of Mental Health and Heidelberg University. Her research aims to identify imaging endophenotypes to accelerate drug development for psychiatric disorders.

Joseph McCabeمشاهده پروفایل

استاد

• Traumatic Brain Injury
• Behavioral Neuroscience
• Neuropathology
• +۳ مورد دیگر

Joseph McCabe is a Professor and Vice Chair for Faculty Affairs in the Department of Anatomy, Physiology and Genetics at the Uniformed Services University of the Health Sciences (USU) School of Medicine. He also holds secondary appointments as Professor of Neuroscience and Professor of Molecular & Cell Biology. With a distinguished career spanning over three decades, Dr. McCabe serves as the Program Director for Neuroprotection and Modeling of The Center for Neuroscience and Regenerative Medicine. His work bridges basic neuroscience with translational applications for military-relevant brain injuries. Dr. McCabe's educational background includes: Bachelor of Arts from Rutgers College (1974) Master of Science in Clinical Psychology from University of Wisconsin-Oshkosh (1976) Master of Philosophy and Ph.D. in Neuropsychology from City University of New York (1983) His research primarily focuses on traumatic brain injury mechanisms and neuroprotective strategies, with particular emphasis on understanding cellular stress responses and developing pharmacological interventions to mitigate functional consequences of brain trauma. Dr. McCabe's laboratory investigates sex differences in TBI outcomes, blast-related injuries, and the molecular pathways involved in neuronal recovery. His work has significant implications for military medicine given the prevalence of blast injuries among service members. Analysis of Dr. McCabe's recent publications reveals a strong focus on blast-induced traumatic brain injury, with particular attention to sex differences, white matter pathology, and behavioral outcomes. His team has developed and refined the CHIMERA (Closed-Head Impact Model of Engineered Rotational Acceleration) model as a key tool for studying TBI mechanisms. The publications span neuroscience, neuroimaging, behavioral analysis, and molecular biology, reflecting a highly interdisciplinary approach to understanding brain injury and recovery processes. Among his notable recognitions: First recipient of the University's F. Edward Hébert School of Medicine Outstanding Biomedical Graduate Educator Award (1998) USUHS President's Outstanding Service Medal (2012) F. Edward Hébert School of Medicine Impact Award (2015) Dr. McCabe has led significant research initiatives including the Program Director for Neuroprotection and Modeling at The Center for Neuroscience and Regenerative Medicine (2008-2020). His grant portfolio demonstrates expertise in TBI modeling, neuroprotective strategies, and sex-based differences in injury response. He has mentored numerous researchers in the field of neurotrauma and continues to advance understanding of cellular stress responses following brain injury. His laboratory maintains a strong focus on translational neuroscience, developing models that bridge basic cellular mechanisms with clinical applications for traumatic brain injury. The team employs advanced techniques including high-speed imaging of impact devices, molecular analysis of stress responses, and comprehensive behavioral assessments to characterize injury mechanisms and potential therapeutic interventions.

David Rudkoمشاهده پروفایل

دانشیار

• Neuroimaging
• MRI Methodology
• Biophysical Modeling
• +۵ مورد دیگر

David Rudko is an Associate Professor and Director of the 7T Pre-Clinical MRI Unit at the Montreal Neurological Institute-Hospital (The Neuro), a bilingual academic healthcare institution and McGill University research and teaching institute. He is part of the Brain Imaging Centre (BIC) Core Faculty and serves as a Killam Scholar. His work bridges advanced MRI technology development with neurological disease research, particularly focusing on multiple sclerosis and other neuroimmunological conditions. Dr. Rudko's research centers on the application of novel MRI methodology in conjunction with biophysical modeling to enhance understanding of brain anatomy and physiology. His laboratory develops cutting-edge MRI physics acquisition and post-processing techniques for mapping myelin density, axonal packing, and axonal geometry. A key focus is on ultra-high field (UHF, >3T) MRI, where his team addresses critical challenges including RF field homogenization and static magnetic field inhomogeneities. The lab utilizes both small animal (7T) and human MRI/MRS (3T, 7T) systems in conjunction with optical microscopy and advanced image processing methods. Analysis of Dr. Rudko's recent publications reveals a strong emphasis on multiple sclerosis research using advanced MRI techniques. His work spans from fundamental MRI physics development to clinical applications, with particular attention to cortical pathology, white matter lesions, and iron metabolism in neurological disorders. His research group has made significant contributions to understanding the microstructural basis of neurological diseases through innovative imaging approaches that bridge cellular-level observations with macroscopic imaging metrics. Killam Scholar Dr. Rudko leads the Rudko Lab, which is affiliated with both the Neuroimaging and Neuroinformatics Research Group and the Neuroimmunological Diseases Research Group at The Neuro. His laboratory focuses on developing and applying advanced MRI techniques to understand the cellular and microstructural basis of neurological diseases, with particular emphasis on multiple sclerosis. The lab utilizes a multidisciplinary approach combining physics, engineering, neuroscience, and clinical medicine to advance both the technical capabilities of MRI and its applications to neurological disorders.

• Neuroscience
• Neuroimaging
• Brain Stimulation
• +۳ مورد دیگر

Corey Keller, Associate Professor at Stanford University , specializes in neuroscience, neuroimaging, and brain stimulation . His work focuses on transcranial magnetic stimulation (TMS) mechanisms, neural plasticity, and treatment-resistant psychiatric disorders. He teaches graduate research courses and advanced bioengineering labs across multiple departments. Key research areas: TMS/EEG biomarkers, depression neurophysiology, and neural network modeling Recent work emphasizes machine learning applications for predicting rTMS outcomes and decoding pain states Developed open-source tools like NaviNIBS for brain stimulation applications Scientific Contributions: Investigates cortical excitability, connectivity gradients, and non-invasive neuromodulation in depression and addiction. Combines intracranial recordings with whole-brain modeling to map stimulation effects.

• Neuroscience
• Neurology
• Psychiatry
• +۵ مورد دیگر

Danqing Xiao is an Assistant Professor in the STEM department at Regis College, where she has been a faculty member since 2013. She previously served as an adjunct assistant professor at MCPHS University and teaching fellow at Boston University, and completed postdoctoral training at Harvard Medical School/Massachusetts General Hospital in Neurology and Psychiatry. Her educational background spans multiple disciplines: PhD in Neuroscience, Boston University, 2003 MS in Pharmacology, SUNY Upstate Medical University, 1997 MS in Entomology, Institute of Zoology, Chinese Academy of Science, 1993 BS in Radiologic Sciences, MCPHS University, 2012 BS in Biology, Henan Normal University, 1990 Dr. Xiao's research investigates functional brain connectivity mechanisms in neurological and psychiatric disorders, with primary focus on Alzheimer's and Parkinson's diseases. She employs neuroimaging techniques like diffusion tensor imaging and genetic association studies to identify biomarkers and evaluate pharmacological/alternative therapies. Her work bridges basic neuroscience with clinical applications, particularly in monitoring disease progression and developing therapeutic interventions. Analysis of her 15 most recent publications (2002-2022) reveals a strong trajectory toward Alzheimer's disease research since 2020, utilizing advanced neuroimaging and genetic methodologies to explore cognitive decline biomarkers. Earlier work (2004-2010) centered on Parkinson's disease mechanisms, especially adenosine receptor roles in L-DOPA-induced dyskinesia, demonstrating consistent expertise in neurodegenerative disease pathophysiology. Her scientific recognition includes: Postdoctoral fellowship award from American Parkinson’s Disease Association (APDA), 2006-2007 SMRT John A. Koveleski Award recipient, 2012-2013 Dr. Xiao has secured significant research funding as Principal Investigator on three Kaneb Faculty Scholar Grants (2020-2022) for Alzheimer's disease biomarker studies and an APDA grant (2006-2007), plus collaborative grants for neuroscience program development. She actively mentors students through Regis College's independent study courses and established internship partnerships with McLean Hospital and MGH, supervising research leading to college presentations. As a member of the International Society of Magnetic Resonance in Medicine (ISMRM) and Society for Neuroscience, she maintains active engagement in professional networks driving innovation in neurodegenerative disease research.

Joyce Besheerمشاهده پروفایل

استاد

• Alcohol Use Disorders
• Addiction Neuroscience
• Stress and Addiction
• +۷ مورد دیگر

Dr. Joyce Besheer is a Professor and Associate Director at the Bowles Center for Alcohol Studies within the Department of Psychiatry at the University of North Carolina at Chapel Hill School of Medicine. Her research program focuses on understanding the neural mechanisms underlying alcohol use disorders and drug addiction, with particular emphasis on how stress impacts drinking behavior and sensitivity to alcohol-related cues. Dr. Besheer's research interests center on the neurobiological adaptations that occur following stress exposure and how these changes influence alcohol consumption and relapse. She investigates glutamatergic systems and cortical and limbic brain circuitry, examining how stress affects sensitivity to both external environmental cues and internal interoceptive effects of alcohol. Her work also explores neural circuitry underlying alcohol's interoceptive effects and low-dose alcohol molecular targets, along with collaborations examining neuroimmune system activation, neurosteroids' role in drinking regulation, and novel therapeutic targets for alcohol use disorder. Analysis of Dr. Besheer's recent publications reveals a consistent focus on the intersection of stress, neural circuitry, and alcohol use disorder. Her work spans multiple disciplines including neuroscience, pharmacology, and behavioral psychology, with particular emphasis on glutamatergic transmission, interoception, and neuroimmune mechanisms. The publications demonstrate progression from basic mechanisms to potential therapeutic applications, with increasing focus on specific receptor systems and neural circuits involved in alcohol use disorder. Dr. Besheer leads the Besheer Lab at UNC Chapel Hill, where her team conducts preclinical research examining the lasting effects of stress on neurobiological adaptations and their impact on alcohol consumption patterns. Her work has significant implications for understanding how stressful episodes or trauma can promote excessive drinking and maladaptive drinking patterns in humans, with the ultimate goal of identifying novel targets for therapeutic treatment of drug and alcohol addiction.

Deborah Kreissمشاهده پروفایل

دانشگاهی

• Neurobiology
• Obsessive Compulsive Disorder (OCD)
• Animal Models in Psychiatry
• +۳ مورد دیگر

Deborah Kreiss is a Research Assistant Professor in the Department of Psychology at Binghamton University. She leads research on the neurobiology of Obsessive Compulsive Disorder (OCD) using rodent models, focusing on serotonin-norepinephrine pathways and behavioral interventions. Her work explores novel treatments targeting cortical-basal ganglia-limbic circuits. She advises the First-year Research Immersion Program (Neuroscience Stream) and teaches Psychopharmacology and Behavioral Neuroscience courses. Education: Postdoctoral Fellowship: National Institutes of Neurological Disorders & Stroke PhD: University of Pennsylvania BA: Cornell University Research Focus: Developing animal models for OCD and anxiety disorders, evaluating drug efficacy in psychiatric treatments, and studying neurochemical mechanisms underlying psychoactive agents' effects. Techniques include behavioral assays, histology, and neurochemical analysis. Publications: Her work spans OCD modeling, Parkinson’s disease neurophysiology, and antidepressant pharmacology. Recent studies investigate mCPP-induced behaviors as OCD proxies and subthalamic nucleus activity in PD. Advising & Grants: Mentors undergraduate researchers (12+ listed), focusing on OCD and neuropharmacology projects. Collaborates with NIH-funded initiatives on psychiatric disorder models. Labs & Teams: Conducts research in Binghamton’s Neuroscience department, emphasizing translational models linking rodent studies to human psychiatric conditions.

John Greenمشاهده پروفایل

استاد

• Neurobiology of Learning and Memory
• Behavioral Neuroscience
• Cerebellar Function
• +۳ مورد دیگر

John Green is a Professor in the Department of Psychological Science at the University of Vermont (UVM), affiliated with the Biobehavioral Psychology program. His research focuses on the neurobiology of learning and memory, using rodent models to study Pavlovian and instrumental conditioning. Key areas include the medial prefrontal cortex's role in context-dependent behaviors and goal-directed actions, as well as cerebellar functions in associative learning. He collaborates with Professor Mark Bouton's lab to explore neural substrates of instrumental behavior transitions from goal-directed to habitual responses. Education: B.A. from Drexel University (1990), M.A. and Ph.D. from Temple University (1996–1998). His work integrates behavioral neuroscience techniques, such as chemogenetic inhibition and electrophysiological recordings, to dissect neural circuits underlying learning and memory. Recent studies highlight the prelimbic cortex's critical role in context processing and early goal-directed behavior, while the infralimbic cortex mediates habitual behavior transitions. Research also examines early life stress effects on cerebellar-dependent learning and endocannabinoid systems. He has investigated eyeblink classical conditioning as a model for cerebellar learning mechanisms, exploring pharmacological and molecular interventions (e.g., mGluR1/5 agonists, PKMζ inhibitors). His lab's work bridges basic neuroscience with translational insights into clinical conditions affecting learning and memory. Advising and Grants: While specific grants are not listed, his research is likely supported by grants focused on behavioral neuroscience and neurobiology. He mentors students in experimental psychology, emphasizing neurobehavioral mechanisms and rodent modeling. Collaborations extend to institutions studying attention-deficit/hyperactivity disorder (ADHD) and cerebellar dysfunction in neurodevelopmental disorders. Labs/Teams: His lab at UVM's John Dewey Hall collaborates with the Bouton Lab to develop neurobehavioral models of learning. Facilities include state-of-the-art neurophysiology and behavioral testing equipment for rodent studies.

David Shattuckمشاهده پروفایل

استاد مدعو

• Neuroimaging
• Computational Biology
• Brain Imaging
• +۲ مورد دیگر

David Shattuck is an Adjunct Professor in the Department of Neurology at the University of California Los Angeles (UCLA) School of Medicine. He specializes in neuroimaging and computational neuroscience , with a focus on developing advanced software tools for brain analysis. Academic Affiliation: University of California Los Angeles Department: Neurology Research Focus: Neuroimaging, Brain Segmentation, Cortical Thickness Analysis, Computational Biology Research Contributions: Dr. Shattuck is the principal investigator for NIH R01NS074980 , developing the BrainSuite software suite for multimodal brain imaging analysis and visualization. His work spans human connectome mapping , mouse brain atlases , and neurodegenerative disease imaging . Scientific Trends: His recent publications emphasize deep learning in neuroimaging (e.g., SwinUNETR for mouse brain segmentation), structure tensor analysis for brain tissue orientation, and VR environments for neuroimaging visualization. Keywords across his work include Neuroscience , Medical Informatics , Genetic Disorders , and Biomedical Imaging . Collaborations: Dr. Shattuck collaborates extensively with researchers in neuroimaging genetics , clinical neuroscience , and computational biology , including Arthur Toga, Paul Thompson, and Richard Leahy.

• Neuroscience
• Developmental Neuroscience
• Brain Circuit Development
• +۷ مورد دیگر

Prof. Dr. Ileana L. Hanganu-Opatz is a distinguished Professor at the Center for Molecular Neurobiology Hamburg (ZMNH), part of the University Medical Center Hamburg-Eppendorf's Faculty of Medicine. Her research focuses on the developmental mechanisms underlying brain circuit formation, particularly examining prefrontal-hippocampal networks and their role in cognitive maturation and neuropsychiatric disorders. Her primary research interests include Developmental Neuroscience , Brain Circuit Development , Neuropsychiatric Disorders , and Network Dynamics . Dr. Hanganu-Opatz employs sophisticated techniques including in vivo electrophysiology, optogenetics, and behavioral analysis to investigate how early neural activity patterns shape the development of cognitive functions. Her work has been particularly influential in understanding the developmental origins of network dysfunction in conditions like schizophrenia. Analysis of her publication record reveals a consistent focus on the ontogeny of brain networks, with particular emphasis on prefrontal-hippocampal communication, oscillatory activity patterns during development, and the cellular mechanisms underlying cognitive maturation. Her research bridges basic neuroscience with clinical relevance, aiming to identify early markers of network dysfunction that could inform preventative interventions for neuropsychiatric conditions. Scientific Recognition Recipient of the prestigious DFG Emmy Noether Grant, which supports outstanding early-career researchers in establishing their own independent research groups Dr. Hanganu-Opatz has led multiple significant research projects including the SFB 936/B5 series (across three funding periods from 2011-2023) and the PSYCHOCELL project (2016-2023), which investigated the cellular substrate of abnormal network maturation in neuropsychiatric disorders. Her work has been supported by substantial funding from the German Research Foundation (DFG). Her research is conducted within the Hamburg Center of Neuroscience framework, collaborating with researchers across multiple disciplines including immunology, cardiovascular research, and the Neuro-Immune-Network Hamburg, reflecting the increasingly interdisciplinary nature of modern neuroscience research.

• Neuroimaging
• Biostatistics
• Developmental Psychiatry
• +۱۰ مورد دیگر

Steven M Hodge is an Instructor in the Department of Psychiatry and Behavioral Sciences at UMass Chan Medical School, with additional appointments in the Eunice Kennedy Shriver Center. He serves as the chief statistician at the Child and Adolescent Neurodevelopment Initiative (CANDI), focusing on neuroimaging and biostatistical analysis of neurodevelopmental disorders. Institution: UMass Chan Medical School School: T.H. Chan School of Medicine Department: Psychiatry and Behavioral Sciences Education: B.A. in Psychology and Music, University of Wisconsin at Stevens Point, 1991 M.A. in Cognitive Psychology (emphasis in neuropsychology), Brandeis University, 1996 Mr. Hodge's research centers on biostatistical analysis of human brain imaging data, particularly in autism, bipolar disorder, and schizophrenia. His work aims to understand normative brain development and pathological changes associated with mental illness. He collaborates with Prof. David N. Kennedy on neuroinformatics initiatives to pool and analyze large-scale brain imaging datasets. His expertise lies in data reproducibility, morphometric analysis, and multivariate statistics. The trend in his recent publications (2020–2024) reflects a growing emphasis on data re-executability, open neuroimaging resources (e.g., CANDIShare), and psychological interventions in youth. Earlier work (2003–2015) focused heavily on structural and functional MRI studies of psychiatric disorders, including autism, bipolar disorder, and depression, often exploring cerebellar and limbic system abnormalities. Scientific Contributions: Co-developer of CANDIShare and the Internet Brain Volume Database Key contributor to the ReproNim initiative on reproducible neuroimaging Prolific collaborator in large-scale neuroimaging studies of psychiatric conditions Mr. Hodge has advised numerous research projects as a biostatistician and data scientist, though formal student advisement is not documented. He has not received any publicly listed grants or awards, but his work has been cited over 200 times in high-impact journals. He is a member of the American Statistical Association and has participated in NIH-sponsored methodological summits. He is actively involved in the Neuroinformatics Program at UMass, working to build collaborative environments for data sharing and advanced statistical modeling in child psychiatry research.

• Psychiatry
• Child and Adolescent Psychiatry
• Obsessive-Compulsive Disorder
• +۸ مورد دیگر

Euripedes C. Miguel is Professor and Chair of Child and Adolescent Psychiatry at the Department of Psychiatry, University of São Paulo School of Medicine (USP). He holds adjunct appointments as Associate Professor at the Yale Child Study Center, Yale University School of Medicine, and at the Department of Psychiatry and Behavioral Sciences, Duke University Medical Center. He also serves as Consultant in Research at Massachusetts General Hospital, Harvard Medical School. He is the Coordinator of the National Institute for Developmental Psychiatry (INPD), a leading research center focused on preventive mental health in children and adolescents. PhD, Psychiatry Department, University of São Paulo (1992) PhD, Harvard Medical School, Massachusetts General Hospital (1994) MD, University of São Paulo Medical School (1982) Dr. Miguel's research is centered on obsessive-compulsive disorder (OCD) and related conditions, with a focus on neurobiological mechanisms, clinical trajectories, and public health interventions. His work integrates neuroscience, genetics, and clinical psychiatry to understand the developmental pathways of psychopathology. He has pioneered large-scale studies on OCD, including genome-wide analyses, neuroimaging of brain circuits, and digital cognitive behavioral therapy. His research interests include: Neural circuits in OCD and anxiety disorders Biological markers of psychiatric conditions Developmental psychiatry and early intervention Multicenter clinical trials (e.g., SMART trials for pediatric OCD) Digital mental health and treatment accessibility High-risk cohort studies for psychopathology and resilience His recent publications reflect a strong trend in global collaborative research , with multicenter studies on OCD severity, brain structure, and functional connectivity. He has been instrumental in validating assessment tools like the Yale-Brown Obsessive Compulsive Scale across cultures and languages. His work increasingly emphasizes translational neuroscience and preventive strategies in child mental health. Scientific awards and recognitions include: IPq Award for best research at USP’s Institute of Psychiatry Prof. Ulysses Vianna Filho’s Award (2005, 2006) V Psychiatry Week Award OCDi AWARD from the World Congress of Psychiatry (1996) Dr. Miguel has been actively involved in securing research grants and leading national and international consortia. He founded the Obsessive-Compulsive Spectrum Disorders Program at USP (1994–2009) and continues to mentor a broad network of researchers. His collaborations include frequent co-authorship with leading experts such as James Leckman, Michael Bloch, and Thomas Fernandez at Yale. He plays a key role in advancing interdisciplinary team science in psychiatry. He leads the National Institute for Developmental Psychiatry (INPD) , which conducts longitudinal cohort studies such as the Butantã Birth Cohort and Pregnant Women Cohort, aiming to identify early markers of psychopathology and resilience. The INPD serves as a hub for training, innovation, and policy-relevant research in child mental health in Brazil and beyond.